JARGON ID="NYU_JARGON6665" START="193" END="208" TEXT="BRAF inhibitors"
JARGON ID="NYU_JARGON6664" START="210" END="215" TEXT="BRAFi"
RELATION ID="NYU_RELATION6666" TYPE="ABBREVIATE" START="193" END="215" ARG1="NYU_JARGON6665" ARG1_NAME="FULLNAME" ARG2="NYU_JARGON6664" ARG2_NAME="SHORTNAME" ARG1_TEXT="BRAF inhibitors" ARG2_TEXT="BRAFi" GRAM_SIGNAL="PARENTHESES"
JARGON ID="NYU_JARGON6668" START="218" END="232" TEXT="MEK inhibitors"
JARGON ID="NYU_JARGON6667" START="234" END="238" TEXT="MEKi"
RELATION ID="NYU_RELATION6669" TYPE="ABBREVIATE" START="218" END="238" ARG1="NYU_JARGON6668" ARG1_NAME="FULLNAME" ARG2="NYU_JARGON6667" ARG2_NAME="SHORTNAME" ARG1_TEXT="MEK inhibitors" ARG2_TEXT="MEKi" GRAM_SIGNAL="PARENTHESES"
ENAMEX ID="NYU_ENAMEX6671" TYPE="ORGANIZATION" START="521" END="557" TEXT="European Society of Medical Oncology"
ENAMEX ID="NYU_ENAMEX6670" TYPE="ORGANIZATION" START="559" END="563" TEXT="ESMO"
RELATION ID="NYU_RELATION6672" TYPE="ABBREVIATE" START="521" END="563" ARG1="NYU_ENAMEX6671" ARG1_NAME="FULLNAME" ARG2="NYU_ENAMEX6670" ARG2_NAME="SHORTNAME" ARG1_TEXT="European Society of Medical Oncology" ARG2_TEXT="ESMO" GRAM_SIGNAL="PARENTHESES"
